Absorption |
Blood-Brain Barrier | BBB- | 0.9903 |
Human Intestinal Absorption | HIA+ | 0.8368 |
Caco-2 Permeability | Caco2- | 0.8957 |
P-glycoprotein Substrate | Non-substrate | 0.6204 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8951 |
Non-inhibitor | 0.9204 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9629 |
Distribution |
Subcellular localization | Lysosome | 0.4793 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8262 |
CYP450 2D6 Substrate | Non-substrate | 0.9050 |
CYP450 3A4 Substrate | Substrate | 0.5977 |
CYP450 1A2 Inhibitor | Inhibitor | 0.8592 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8910 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9180 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8832 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8190 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9186 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9996 |
Non-inhibitor | 0.8486 |
AMES Toxicity | Non AMES toxic | 0.6979 |
Carcinogens | Carcinogens | 0.5672 |
Fish Toxicity | High FHMT | 0.9935 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9330 |
Honey Bee Toxicity | Low HBT | 0.7854 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.4590 |
Carcinogenicity (Three-class) | Non-required | 0.5685 |